In this review, we will first present a brief overview of the current understanding of: (a) the biology of reelin; (b) the putative reelin signaling pathways via integrin receptor stimulation; (c) the cytosolic adapter protein DAB1, which appears to be operative in the transduction of reelin's pleiotropic actions in embryonic, adolescent, and adult brain; (d) the regulation of GABAergic function, including some aspects of GABAergic system development; and (e) dendritic spine function and its role in the regulation of synaptic plasticity. We argue that a downregulation of reelin expression occurring in prefrontal cortex and in every brain structure of schizophrenia patients so far studied may be associated with a decrease in dendritic spine expression that in turn may provide an important reduction of cortical function as documented by the downregulation of glutamic acid decarboxylase 67 (GAD 67 ) expression, which might be secondary to a reduction of GABAergic axon terminals. This hypothesis is supported by a genetic mouse model of reelin haploinsufficiency that replicates the above-described dendritic and presynaptic GABAergic defects documented in schizophrenia brains.
INTRODUCTION
There is a confluence of evidence suggesting that genetic neurodevelopmental abnormalities may be a component of the etiology of schizophrenia (Andreasen et al., 1986; Jones & Murray, 1991; Bloom, 1993; Weinberger & Lipska, 1995; Woods, 1998) . Here we present recently acquired information indicating that a downregulation of the reelin gene may be an example of a genetic abnormality that may be considered a factor for schizophrenia vulnerability.
As a group, schizophrenia patients exhibit a loss of brain tissue leading to an increase in cerebral ventricular volume and to an enlargement in the fluid space that surrounds the brain (Johnstone et al., 1976; Bertolino et al., 1998; Weinberger et al., 1986; McCarley et al., 1999; Altshuler et al., 2000; Crespo-Facorro et al., 2000; Falkai et al., 2000) . This ventricular enlargement is believed to have started before the onset of any clinical manifestation of the disease, but studies directed at documenting such a succession of events are not yet available. It is, however, very likely that the process causing brain tissue loss in schizophrenia is not related to neurodegeneration because the gliosis that normally accompanies cell necrosis is virtually absent (Akbarian et al., 1995; Selemon & Goldman-Rakic, 1999) .
Recent reports (Selemon & Goldman-Rakic, 1999) have described a reduction of interneuronal neuropil and an apparent increase in neuronal packing density in the prefrontal cortex (PFC) and other brain struc-
